- Trellus Health, a NYC-based digital health solution for chronic conditions, raised $5m in seed funding
- The round was led by Mount Sinai Health System (MSHS) and EKF Diagnostics
- The company has also entered into an exclusive multi-year contract with MSHS to commercialize its patent pending GRITT-IBDTM resilience assessment
- Trellus Health provides a digital health solution for chronic conditions, with an initial focus in Inflammatory Bowel Disease (IBD)
- Through its multidisciplinary connected care platform, the company coordinates expert whole-person care
- The company leverages its patent-pending GRITT-IBDTM resilience assessment and personalized treatment methodology, developed at the Mount Sinai Health System
